Reprint

Lung Diseases: Chronic Respiratory Infections

Edited by
October 2018
216 pages
  • ISBN978-3-03897-338-6 (Paperback)
  • ISBN978-3-03897-339-3 (PDF)

This book is a reprint of the Special Issue Lung Diseases: Chronic Respiratory Infections that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Both chronic and acute infections play a significant role in the pathogenesis and clinical course of chronic obstructive pulmonary disease (COPD) and both cystic fibrosis (CF) and non-CF bronchiectasis. There is also specific evidence that chronic infection, even in the absence of acute infection, has an influence on the manifestations and disease course. The infections found in COPD, CF, and bronchiectasis share a number of clinical similarities, the most striking of which are bacterial persistence despite the use of antibiotics and antibiotic resistance.

In the last two decades, the rate of antibiotic resistance has increased dramatically and poses serious threats for patients and public health. There are different reasons for this increase in resistance, but the overuse of antibiotics in the community is certainly the most prominent. On the other hand, the chronic use of antibiotics in chronic diseases like COPD, CF, and bronchiectasis is also potentially associated with an increase in MDR pathogens. During the last decade, a growing interest has been raised in evaluating nontuberculous mycobacteria’s role in chronic respiratory diseases like bronchiectasis.

Format
  • Paperback
License
© 2019 by the authors; CC BY license
Keywords
non-cystic fibrosis bronchiectasis; non-tuberculous mycobacteria; pulmonary infection; tuberculosis; osteopontin; galectin-9; CD44; Beijing genotype MTB; taste receptors; chronic rhinosinusitis; mucociliary clearance; airway physiology; biofilm; innate immunity; upper respiratory infection; aerosols; cystic fibrosis; bronchiectasis; nontuberculous mycobacteria; chronic respiratory infections in COPD; exacerbations of chronic obstructive pulmonary disease; antibiotics; bacteria; prevention; colonization; cystic fibrosis; lung disease; lung microbiome; shotgun metagenomics; bioinformatics; metabolic pathways; virulence genes; lung injury; lipopolysaccharide; polydexyribonucleotide; apoptosis; adenosine A2A receptor; Burkholderia cenocepacia; mice; environmental; chronic infection; adaptation; lung tissues; Galleria mellonella; idiopathic pulmonary fibrosis; IPF; interstitial lung diseases; microbiome; microbiota; bronchiectasis; fungi; yeast; filamentous fungi; Candida albicans; Aspergillus; allergic bronchopulmonary aspergillosis; mycobiome; Pseudomonas aeruginosa infections; glycosaminoglycans; anti-inflammatory drugs; mouse models; chronic respiratory diseases; chronic lung inflammation; emphysema; second hand smoke; Bruton’s tyrosine kinase; matrix metalloproteinase-9; sputum galactomannan; Aspergillus PCR; Aspergillus colonization; corticosteroids; antimicrobial; cytoskeleton; Burkholderia; n/a